Related party risks

Bharat Bio-Brazil investigation reveals dangers of offshore agencies

A scandal to do with the alleged approval, import, and procurement of Bharat Biotech’s Covaxin vaccine is rocking the Brazilian government of Jair Bolsonaro. Some lawmakers and prosecutors have accused Bharat Biotech and its Brazilian importer of not going through the right processes; Bharat Biotech has, in response, said that it is following “step by step” the requirements for regulatory approval in Brazil and that no payments eventually fructified. It should be remembered that the Brazilian regulator had earlier denied an application for emergency use authorisation for Covaxin, which had been pushed by the Brazilian government. In the course of